Cas:892501-92-7 6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester manufacturer & supplier

Chemical Name:6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester

CAS.NO:892501-92-7

Synonyms:ethanamine,n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy];6-(2-(dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester;n,n-dimethyl-2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yloxy)ethanamine;a-9250;2-(2-dimethylamino-ethoxy)-pyridine-5-boronic acid pinacol ester;n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]-ethanamine

Molecular Formula:C₁₅H₂₅BN₂O₃

Molecular Weight:292.18200

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:43.82000

Exact Mass:292.19600

LogP:1.32120

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethanamine,n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]-ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,n,n-dimethyl-2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]-ethanamine Use and application,a-9250 technical grade,usp/ep/jp grade.

Related News: No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. 6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester manufacturer As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester supplier In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 6-(2-(Dimethylamino)ethoxy)pyridine-3-boronic acid pinacol ester factory According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.